Novartis Ag (NVS) Cash from Operations (2009 - 2025)

Novartis Ag (NVS) has 13 years of Cash from Operations data on file, last reported at 6664000000.0 in Q2 2025.

• Quarterly Cash from Operations rose 36.7% year-over-year to 6664000000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 25212000000.0 (up 23.66% YoY) and the FY2025 annual result came in at 19144000000.0, up 8.66% from the prior year.
• Cash from Operations slipped to 6664000000.0 in Q2 2025 per NVS's latest filing, from 7140000000.0 in the prior quarter.
• The five-year high for Cash from Operations was 7140000000.0 in Q4 2024, with the low at 3576000000.0 in Q2 2023.
• Average Cash from Operations over 5 years is 5371222222.22, with a median of 5404000000.0 recorded in 2022.
• Year-over-year, Cash from Operations dropped 13.7% in 2022 and surged 36.7% in 2025.
• Novartis Ag's Cash from Operations stood at 6262000000.0 in 2021, then dropped by 13.7% to 5404000000.0 in 2022, then advanced by 20.89% to 6533000000.0 in 2023, then rose by 9.29% to 7140000000.0 in 2024, then dropped by 6.67% to 6664000000.0 in 2025.
• Business Quant data shows NVS's Cash from Operations at 6664000000.0 in Q2 2025, 7140000000.0 in Q4 2024, and 4875000000.0 in Q2 2024.